Patent · US Active

Pharmaceutical compositions

US12311057B2 · kind B2 · utility

0Cited by

14References

30Claims

0Family size

Assignee

CALLIDITAS THERAPEUTICS AB · SE

Inventors

Eva Kristina RIESEL · Mölndal, SE
Lena Pereswetoff-Morath · Spånga, SE
Kari SANDVOLD · Uppsala, SE
Christian Pedersen · Uppsala, SE

Key dates

Filing date	Nov 1, 2024
Grant date	May 27, 2025
Priority date	—
Expiry date	Nov 1, 2044

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides for a method of treatment of IgA nephropathy, which method comprises:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.